Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy

INTRODUCTION: Many studies have focused on the role of programmed death receptor ligand 1 (PD-L1) expression in predicting immunotherapy outcomes. Limited clinical data are available regarding the role of programmed death receptor 1 (PD-1; the PD-L1 receptor) expressing tumor-infiltrating lymphocyte...

Descripción completa

Detalles Bibliográficos
Autores principales: Bevins, Nicholas J., Okamura, Ryosuke, Montesion, Meagan, Adashek, Jacob J., Goodman, Aaron M., Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Innovative Healthcare Institute 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714418/
https://www.ncbi.nlm.nih.gov/pubmed/36483582
http://dx.doi.org/10.36401/JIPO-22-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714418/
https://www.ncbi.nlm.nih.gov/pubmed/36483582
http://dx.doi.org/10.36401/JIPO-22-9

Ejemplares similares